Antithrombotic therapy: COMPASS points to low-dose rivaroxaban and aspirin for secondary prevention
Sign Up to like & getrecommendations! Published in 2017 at "Nature Reviews Cardiology"
DOI: 10.1038/nrcardio.2017.148
Abstract: Antithrombotic therapy: COMPASS points to low-dose rivaroxaban and aspirin for secondary prevention read more here.
Keywords: low dose; dose rivaroxaban; therapy compass; points low ... See more keywords
Characteristics and clinical outcomes of Japanese patients with venous thromboembolism receiving under-dose rivaroxaban: subanalysis of J’xactly
Sign Up to like & getrecommendations! Published in 2022 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2022.2070379
Abstract: Abstract Objective Rivaroxaban is commonly prescribed to prevent venous thromboembolism (VTE). Although lower than standard dosages (under-dosing) may be administered in the real-world setting, data on subsequent clinical outcomes in Japanese patients are lacking. Methods… read more here.
Keywords: clinical outcomes; dose rivaroxaban; japanese patients; venous thromboembolism ... See more keywords
Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials.
Sign Up to like & getrecommendations! Published in 2021 at "European journal of preventive cardiology"
DOI: 10.1093/eurjpc/zwab128
Abstract: AIMS Peripheral artery disease (PAD) patients suffer a high risk of major cardiovascular (CV) events, with athero-thrombo-embolism as the underlying pathophysiologic mechanism. Recently, two large randomized clinical trials evaluated the efficacy and safety of low-dose… read more here.
Keywords: low dose; analysis; dose rivaroxaban; aspirin ... See more keywords
Efficacy of low-dose rivaroxaban in an 88-year-old female with pulmonary embolism
Sign Up to like & getrecommendations! Published in 2019 at "Medicine"
DOI: 10.1097/md.0000000000015705
Abstract: Rationale: Rivaroxaban has numerous advantages over traditional anticoagulation therapy. Fixed doses can be administered without requiring routine monitoring of coagulation, and anticoagulation efficacy is more predictable. Safety, including fewer drug interactions, and reduced bleeding, is… read more here.
Keywords: patient; low dose; pulmonary embolism; dose rivaroxaban ... See more keywords
Single-Dose Rivaroxaban-Induced Acute Liver Injury.
Sign Up to like & getrecommendations! Published in 2018 at "American Journal of Therapeutics"
DOI: 10.1097/mjt.0000000000000799
Abstract: tic agents. Only 10.5% of treatment-related adverse effects occurred after pembrolizumab monotherapy, such as loss of appetite, fatigue, and vomiting. OS and adverse effects were observed in patients with selected advanced stage III or IV… read more here.
Keywords: dose rivaroxaban; acute liver; rivaroxaban induced; advanced stage ... See more keywords
Low Dose Rivaroxaban for Atherosclerotic Cardiovascular Diseases: A Systematic Review and Meta-analysis
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2020.608247
Abstract: Background: This study aims to explore the role of low-dose rivaroxaban (≤10 mg daily) for the treatment of atherosclerotic cardiovascular disease (ASCVD). Methods: PubMed, Embase and the Cochrane Library were searched for randomized controlled trials… read more here.
Keywords: cardiovascular; low dose; dose rivaroxaban; meta analysis ... See more keywords
Is a Lower Dose of Rivaroxaban Required for Asians? A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban
Sign Up to like & getrecommendations! Published in 2023 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics15020588
Abstract: Rivaroxaban has been widely used to prevent and treat various thromboembolic diseases for more than a decade. However, whether a lower dose of rivaroxaban is required for Asians is still debatable. This review aimed to… read more here.
Keywords: review; dose rivaroxaban; required asians; rivaroxaban ... See more keywords